MenQuadfi Dosage
Generic name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL
Dosage form: solution for intramuscular injection
Medically reviewed by Drugs.com. Last updated on May 23, 2025.
Preparation for Administration
MenQuadfi is a clear, colorless solution.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered.
Dose and Schedule
Administer MenQuadfi as a single 0.5 mL injection intramuscularly.
Primary Vaccination:
Age at First Dose | Primary Vaccination Schedule |
---|---|
2 months | 4-dose series at 2, 4, 6, and 12 through 18 months of age. The first dose may be given as early as 6 weeks. |
6 months through 11 months | 2-dose series with the second dose administered in the second year of life and at least 3 months after the first dose. |
12 months through 23 months | 2-dose series with the second dose administered at least 3 months after the first dose. |
2 years and older | A single dose |
More about MenQuadfi (meningococcal conjugate vaccine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- En español
Patient resources
- MenQuadfi drug information
- MenQuadfi (Meningococcal vaccine, tetanus toxoid conjugate quadrivalent Intramuscular) (Advanced Reading)
Other brands
Professional resources
Other brands
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.